FECOTAINER® The most reliable method for stool collection

Slides:



Advertisements
Similar presentations
High Resolution studies
Advertisements

EC Admin Functionality Enhancements December 2001 Release
TWO STEP EQUATIONS 1. SOLVE FOR X 2. DO THE ADDITION STEP FIRST
3/25/2017 Social Jessica Winters
Bellwork If you roll a die, what is the probability that you roll a 2 or an odd number? P(2 or odd) 2. Is this an example of mutually exclusive, overlapping,
Slide 1 Insert your own content. Slide 2 Insert your own content.
QUALITY CONTROL TOOLS FOR PROCESS IMPROVEMENT
Chapter 1 The Study of Body Function Image PowerPoint
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
1 Physicians Involved in the Care of Patients with Recently Diagnosed Cancer CanCORS Provider Composition Writing Group Academy Health Annual Research.
We need a common denominator to add these fractions.
State of New Jersey Department of Health and Senior Services Patient Safety Reporting System Module 2 – New Event Entry.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Title Subtitle.
© 2009 Group Health Cooperative 1. 2 Recognize how nutrition plays an important role in providing fuel and nutrients Learn about Dietary Reference Intake.
0 - 0.
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
MULTIPLYING MONOMIALS TIMES POLYNOMIALS (DISTRIBUTIVE PROPERTY)
ADDING INTEGERS 1. POS. + POS. = POS. 2. NEG. + NEG. = NEG. 3. POS. + NEG. OR NEG. + POS. SUBTRACT TAKE SIGN OF BIGGER ABSOLUTE VALUE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Addition Facts
ZMQS ZMQS
Objectives How the heart functions What a heart attack is
1 Preparing for Smallpox: Post-event Smallpox Response.
Integrated Cancer Screening Day November 10, 2012.
Massachusetts Centralized Clinical Placement System© Clinical Faculty Introduction to the Online Orientation Massachusetts Department of Education A Presentation.
© S Haughton more than 3?
Audit of patients diagnosed with colorectal cancer within the eligible age group for bowel cancer screening Clare Westwood Colorectal Nurse Consultant.
Occupational Health and Safety Accident Investigation Training HS6_
© 2012 National Heart Foundation of Australia. Slide 2.
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
This, that, these, those Number your paper from 1-10.
Addition 1’s to 20.
25 seconds left…...
Bowel Cancer screening programme The Facts Third most common Cancer in the UK. The Second most common cause of cancer deaths in the UK (approx 16,100.
Test B, 100 Subtraction Facts
11 = This is the fact family. You say: 8+3=11 and 3+8=11
Week 1.
Number bonds to 10,
Section 16.4 Saying No to Tobacco Objectives
We will resume in: 25 Minutes.
1 Ke – Kitchen Elements Newport Ave. – Lot 13 Bethesda, MD.
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
The tool that could change everything 1 The Tool that could for Employees Change Everything.
12-CRS-0106 REVISED 8 FEB 2013 PRESENTS Payment Functionality.
1 Colorectal Cancer and Screening Cancer Screening Programs September 2013.
Welcome! Colon Health, it’s not just about Cancer. Philip N Styne, MD AGAF Medical Director Digestive Health Center.
Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.
What is cancer? A group of 100 different diseases The uncontrolled, abnormal growth of cells Cancer may spread to other parts of the body Source:
Colorectal Cancer & Screening Sept Sometimes there are things that may be hard to talk about… But not talking about them is even harder.

Mobilizing Newcomers and Immigrants to Cancer Screening Programs Funded by Public Health Agency of Canada (PHAC) The views expressed herein do not necessarily.
Integrated Cancer Screening Colorectal Cancer Screening.
The Digestive System. Diagram of the digestive system.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Prevention and Health Promotion Administration May Overview of Colorectal Cancer Maryland Department of Health & Mental Hygiene Prevention and Health.
The Importance of Stool Occult Blood Tests in Getting to 80% Durado Brooks, MD, MPH Director, Cancer Control Interventions American Cancer Society.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
A Pharmacy Based Bowel Cancer Screening Program. Did You Know? Bowel cancer kills more Australians each year than breast or prostate cancer (AIHW 2012.
Immunochemical Fecal Occult Blood Testing
Colorectal Cancer Screening Guidelines
What you need to know about the Fecal Occult Blood Test
Different Tests to Detect Colonic Polyps
27th Annual Winter CME Conference
Colorectal Cancer Screening
Module 4: Colorectal Cancer
Citation: Cancer Care Ontario
The Research Question Flexible sigmoidoscopy (FS) is the only cancer screening modality (for any type of cancer) to reduce all-cause mortality compared.
Presentation transcript:

FECOTAINER® The most reliable method for stool collection Alain le Loux MSc. MBA AT Medical BV, The Netherlands 1

Topics The feces of people says a lot about their health 1 More research into cancer prevention 2 Current methods of collection of stool 3 The FECOTAINER®: a unique stool collector 4 The FECOTAINER®: a patented disposable 5 Save on transmission price 6 Characteristics FECOTAINER® 7 Contact details 8 Page  2

Faeces research provides a lot of information The faeces of people reveals a lot about their health and thus plays an important role in the early identification of diseases, including colorectal cancer. Bacteriological research: Infections Chronic intestinal inflammation (Crohn’s disease, Ulcerative colitis) Colorectal cancer Obesity Diabetes Mellitus Research on blood in stool Precancerous colorectal cancer immunochemical Fecal Occult Blood Testing (iFOBT) Intestinal function Digestion Helicobacter pylori Salmonella, Shigella Campylobacter Yersinia enterocolitica Page  3

The EU wants more preventive research into cancer With more than 3 million new cases and 1.7 million deaths each year, cancer is the second biggest cause of death in Europe. Colorectal cancer is the second mortally cancer in Europe. In the early diagnosis is the chance of recovery 90%. This is possible with occult blood testing. 90% of cases of cancer occur of people over 50 years. The EU asks the Member States to roll- out preventive colorectal cancer screening programs. Page  4

Faecal Occult Blood Test The stool examination is an examination of very small amounts of blood in stool. This is the immunochemical Fecal Occult Blood Test (iFOBT). The stool will be checked in the laboratory under a microscope. Blood in the stool sample may indicate a polyp or tumour in the intestines, or may have other, more innocent causes. If blood is found in the FOBT test, the doctor will discuss with the patient if further investigation is needed. In the most cases there is an endoscopy investigation needed. Page  5

Current methods of collection of feces Gathering / collecting portion stool: The patient should caught the feces itself in a pot, pan, garbage bag or newspaper A portion of the feces must be scooped into the plastic feces jar For the patients this is very inconvenient ! Problems with the current collection methods: The feces jar will be inappropriate handed (e.g. too less filled) or smeared on the outside Incorrect intake provides unreliable research and threatens the health of laboratory employees Consequence: research delayed and intake should happen again Page  6

Current methods Page  7

FECOTAINER®: a unique faeces collector The FECOTAINER® (faeces collector) has the following properties: User-friendly for patients and laboratory maximum comfort for patients (no spading of faeces, but easy to absorb) fits in the mail (only 28mm high) because of the sliding tray strong and flexible material the cover protects the feces Page  8

The FECOTAINER®: a unique stool collector 15 cm 9 cm Page  9

The FECOTAINER®: a unique stool collector Page  10

The FECOTAINER®: a patented disposable Page  11

Characteristics FECOTAINER® A unique stool collector. Offers patients a user-friendly and hygienic stool collection method. Ideal tool for large-scale population studies (iFOBTs) / colorectal cancer screening. Increases the participation in colorectal cancer screening programs Patented product. Is collapsible and can fit trough a letterbox (only 28mm high) and therefore easy to send to patients. The material is from recycle bar plastic and the supplied plastic bag is from biodegradable plastic. After ingestion and laboratory use, the FECOTAINER® can be wasted as a normal disposable. A Dutch invention and recommended by doctors. The FECOTAINER® provides the most reliable results in laboratory stool tests. Veel tekst, korter! Page  12

FECOTAINER® : A unique stool collector The most reliable method for stool collection. Reliable results ! Best method for stool collection. Increases the participation in colorectal cancer screening DEVELOPED AND PRODUCED IN THE NETHERLANDS. MADE IN HOLLAND PATENT N2004507 Page  13

Contact Company Website & e-mail AT MEDICAL BV Postbus 78077 1070LP AMSTERDAM THE NETHERLANDS WTC – AMSTERDAM Strawinskylaan 9, Amsterdam Tel: +31 20 334 20 61 Fax: +31 20 716 53 81 www.fecotainer.eu info@fecotainer.eu Page  14

www.fecotainer.eu Page  15

Page  16

Page  17

Page  18